[Skip to Navigation]
Comment & Response
August 2014

Drug Treatment of Obesity

Author Affiliations
  • 1President, The Obesity Society
  • 2Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Sanford-Burnham Medical Research Institute, Orlando
JAMA Intern Med. 2014;174(8):1414-1415. doi:10.1001/jamainternmed.2014.1646

To the Editor The Obesity Society, of which I am the president, is concerned with Woloshin and Schwartz’s dismissal of obesity as a disease, disregard for the well-established benefits of modest weight loss, and focus on cardiovascular risk as the sole reason to treat obesity.1

The authors declare, “obesity is not an emergency, it is not even a disease.1(p618) Many diseases are not emergencies yet still warrant medical intervention. In fact, the American Medical Association recently joined The Obesity Society, the American Association for Clinical Endocrinologists, the World Health Organization, the National Institutes of Health, and the Food and Drug Administration (FDA), among many others, in classifying obesity as a disease.2

Add or change institution